GINKGO BIOWORKS HOLDINGS, INC. (DNA) Return on equity 2019–2025
GINKGO BIOWORKS HOLDINGS, INC. (DNA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-61.5%FY2025 · since FY2019: -24.2% → -61.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -61.5% | +14.9 pp |
| FY2024 | -76.4% | +5.0 pp |
| FY2023 | -81.4% | +39.9 pp |
| FY2022 | -121.2% | +0.3 pp |
| FY2021 | -121.6% | -94.1 pp |
| FY2020 | -27.4% | -3.2 pp |
| FY2019 | -24.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice